Related Experiment Video
Updated: Aug 7, 2026

A Dual Task Procedure Combined with Rapid Serial Visual Presentation to Test Attentional Blink for Nontargets
Published on: December 5, 2014
Inhibition of return for expected and unexpected targets
1Department of Psychology, Life Sciences Center, Dalhousie University, Halifax, Nova Scotia, Canada. ttaylor2@dal.ca
Abstract:
Inhibition of return (IOR) refers to slower reaction times (RTs) to targets that occur in the same, rather than in a different, location as a preceding onset cue. The present study examined IOR for expected (likely) and unexpected (unlikely) targets under conditions in which stimulus-response (S-R) expectancies were generated on a trial-by-trial basis or maintained across a block of trials. Three boxes were aligned along the vertical midline. In Experiments 1 and 2, the appearance of a cue in the upper or lower box was a signal to generate an expectancy about the most likely color of an impending discrimination target. In Experiment 3, one target color was more likely than another across a block of trials. In all cases, cue location did not predict target location. When S-R expectancies were generated on a trial-by-trial basis, IOR occurred for Unlikely targets but not for Likely targets; this was true across a range of cue-target stimulus onset asynchronies. In contrast, when S-R expectancies were maintained over a block of trials, IOR was larger for Likely than for Unlikely targets. These findings reveal a critical interaction of S-R expectancies with IOR. This interaction not only demonstrates the modulation of IOR by cognitive expectancies, but in doing so also provides evidence that is consistent with the view that IOR reflects a conservative response bias.
Related Concept Videos
Enzyme Inhibition
Feedback Inhibition
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...

